5-azacytidine treatment reorganizes genomic histone modification patterns.
Komashko
Vitalina M
VM
Farnham
Peggy J
PJ
D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D001374:Azacitidine / Q000494:pharmacology*; D045744:Cell Line, Tumor; D019175:DNA Methylation; D005786:Gene Expression Regulation; D015894:Genome, Human; D057809:HEK293 Cells; D000076983:Histone Methyltransferases; D011495:Histone-Lysine N-Methyltransferase / Q000378:metabolism; D006657:Histones / Q000378:metabolism*; D006801:Humans; D011401:Promoter Regions, Genetic; D011499:Protein Processing, Post-Translational / Q000187:drug effects*
D000964:Antimetabolites, Antineoplastic; D006657:Histones; D000076983:Histone Methyltransferases; D011495:Histone-Lysine N-Methyltransferase; D001374:Azacitidine